首页> 外文期刊>European journal of clinical pharmacology >Prescribing indicators. Development and validation of guideline-based prescribing indicators as an instrument to measure the variation in the prescribing behaviour of general practitioners.
【24h】

Prescribing indicators. Development and validation of guideline-based prescribing indicators as an instrument to measure the variation in the prescribing behaviour of general practitioners.

机译:规定指标。制定和验证基于指南的处方指标,以此作为衡量全科医生处方行为变化的工具。

获取原文
获取原文并翻译 | 示例
           

摘要

BACKGROUND: Differences in prescribing behaviour among general practitioners (GPs). AIM: To formulate and validate clinical prescribing indicators based on general practice guidelines. DESIGN: Validatory study. SETTING: Pharmacies and general practices in the Netherlands in 2003. PARTICIPANTS: A total of 379 pharmacies, 947 general practices and 3.8 million patients. METHODS: A total of 51 potential indicators were formulated, based on medicinal recommendations from the evidence-based guidelines of the Dutch College of General Practitioners and the corresponding recommendations from the Commission Pharmaceutical Help of the Health Care Insurance Board. These indicators were submitted to an expert panel to assess content validity. The panel assessment was analysed using the RAND-UCLA appropriateness method (RAM). Then, for the remaining indicators, it was assessed to what extent these could be used to determine the prescribing behaviour of GPs and the level to which this behaviour varies among GPs. Thiswas done using a prescribing analyses and cost (PACT) database that was compiled from prescription databases from 379 pharmacies, with all prescriptions from 1,434 GPs over an entire year to 3.8 million patients. RESULTS: The panel considered 34 of the 51 potential indicators to be valid with respect to providing an adequate reflection of the central recommendations in the guideline and in terms of relevance with respect to health gain and/or efficiency. Of these 34 indicators, 20 revealed considerable differences in the prescribing behaviour of GPs. CONCLUSION: On the basis of existing general practice guidelines, 20 prescribing indicators could be formulated that were assessed by an expert panel to be sufficiently valid and which could also discriminate the prescribing behaviour of GPs as reflected in the prescription databases of pharmacies.
机译:背景:全科医生(GP)的处方行为存在差异。目的:根据一般实践指南制定和验证临床处方指标。设计:验证性研究。地点:2003年在荷兰的药房和全科医师。参与者:总共379家药房,947家全科医师和380万患者。方法:根据荷兰全科医师学院循证指南的医学建议和卫生保健保险委员会药物帮助委员会的相应建议,共制定了51项潜在指标。这些指标已提交给专家小组以评估内容的有效性。使用RAND-UCLA适当性方法(RAM)分析专家组评估。然后,对于其余指标,评估了这些指标可在多大程度上用于确定GP的处方行为以及该行为在GP之间的变化程度。这是通过使用处方分析和成本(PACT)数据库完成的,该数据库是从379家药房的处方数据库中汇编而来的,整个一年中,所有处方均来自1,434名全科医生,共380万患者。结果:专家组认为,在充分反映指南中的主要建议以及与健康增益和/或效率相关的方面,51个潜在指标中的34个是有效的。在这34项指标中,有20项表明GP的处方行为存在很大差异。结论:根据现有的通用指南,可以制定20个处方指标,这些指标由专家小组评估为足够有效,并且还可以区别药房处方数据库中反映的GP的处方行为。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号